Takeda Pharmaceutical Discontinued
FDA Approved Drugs

Takeda Pharmaceutical Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 31
  • Latest Approval Date Sep 15, 2021
  • Data Source FDA
  • First Approval Date Dec 30, 1988
All
123
View
Unclassified
8
View
Discontinued
31
View
RX
84
View
Company Overview

Company

Takeda Pharmaceutical Discontinued

Country

Japan

Email

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Takeda Pharmaceutical Discontinued

1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8668

Japan

www.takeda.com/ View on Map
FDA Approved Drug Records ( 31 records )
2005
29 Aug
Discontinued Application: 21842

Drug Name

ACTOPLUS MET

Product Number

1

Dosage Form

-

Strength

500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2005-08-29

21842 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Application Number

21842

Product Number

1

Dosage Form

-

Strength

500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2005-08-29

Regulatory Status

Discontinued

2009
12 May
Discontinued Application: 22024

Drug Name

ACTOPLUS MET XR

Product Number

1

Dosage Form

-

Strength

1GM;EQ 15MG BASE

Approval Date

2009-05-12

22024 / 1

Active Ingredient

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Application Number

22024

Product Number

1

Dosage Form

-

Strength

1GM;EQ 15MG BASE

Approval Date

2009-05-12

Regulatory Status

Discontinued

2009
12 May
Discontinued Application: 22024

Drug Name

ACTOPLUS MET XR

Product Number

2

Dosage Form

-

Strength

1GM;EQ 30MG BASE

Approval Date

2009-05-12

22024 / 2

Active Ingredient

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Application Number

22024

Product Number

2

Dosage Form

-

Strength

1GM;EQ 30MG BASE

Approval Date

2009-05-12

Regulatory Status

Discontinued

1997
14 Mar
Discontinued Application: 20333

Drug Name

AGRYLIN

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1997-03-14

20333 / 2

Active Ingredient

ANAGRELIDE HYDROCHLORIDE

Application Number

20333

Product Number

2

Dosage Form

-

Strength

EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1997-03-14

Regulatory Status

Discontinued

1988
30 Dec
Discontinued Application: 50601

Drug Name

CERADON

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

1988-12-30

50601 / 1

Active Ingredient

CEFOTIAM HYDROCHLORIDE

Application Number

50601

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

1988-12-30

Regulatory Status

Discontinued

2009
29 Jul
Discontinued Application: 22352

Drug Name

COLCRYS

Product Number

1

Dosage Form

-

Strength

0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2009-07-29

22352 / 1

Active Ingredient

COLCHICINE

Application Number

22352

Product Number

1

Dosage Form

-

Strength

0.6MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2009-07-29

Regulatory Status

Discontinued

2016
26 Jan
Discontinued Application: 208056

Drug Name

DEXILANT SOLUTAB

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2016-01-26

208056 / 1

Active Ingredient

DEXLANSOPRAZOLE

Application Number

208056

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

2016-01-26

Regulatory Status

Discontinued

2021
15 Sep
Discontinued Application: 215310

Drug Name

EXKIVITY

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2021-09-15

215310 / 1

Active Ingredient

MOBOCERTINIB SUCCINATE

Application Number

215310

Product Number

1

Dosage Form

-

Strength

EQ 40MG BASE

Approval Date

2021-09-15

Regulatory Status

Discontinued

2004
26 Oct
Discontinued Application: 21468

Drug Name

FOSRENOL

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-10-26

21468 / 1

Active Ingredient

LANTHANUM CARBONATE

Application Number

21468

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE

Approval Date

2004-10-26

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS

Product Number

7

Dosage Form

-

Strength

EQ 10MG BASE/ML (EQ 10MG BASE/ML)

Approval Date

2012-03-27

202799 / 7

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

7

Dosage Form

-

Strength

EQ 10MG BASE/ML (EQ 10MG BASE/ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS

Product Number

8

Dosage Form

-

Strength

EQ 20MG BASE/2ML (EQ 10MG BASE/ML)

Approval Date

2012-03-27

202799 / 8

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

8

Dosage Form

-

Strength

EQ 20MG BASE/2ML (EQ 10MG BASE/ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 1

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/0.5ML (EQ 1MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 2

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE/0.5ML (EQ 2MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

3

Dosage Form

-

Strength

EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 3

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

3

Dosage Form

-

Strength

EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

4

Dosage Form

-

Strength

EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 4

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

4

Dosage Form

-

Strength

EQ 4MG BASE/0.5ML (EQ 4MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

5

Dosage Form

-

Strength

EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 5

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

5

Dosage Form

-

Strength

EQ 5MG BASE/0.5ML (EQ 5MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2012
27 Mar
Discontinued Application: 202799

Drug Name

OMONTYS PRESERVATIVE FREE

Product Number

6

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)

Approval Date

2012-03-27

202799 / 6

Active Ingredient

PEGINESATIDE ACETATE

Application Number

202799

Product Number

6

Dosage Form

-

Strength

EQ 6MG BASE/0.5ML (EQ 6MG BASE/0.5ML)

Approval Date

2012-03-27

Regulatory Status

Discontinued

2013
25 Jan
Discontinued Application: 22426

Drug Name

OSENI

Product Number

4

Dosage Form

-

Strength

EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-01-25

22426 / 4

Active Ingredient

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Application Number

22426

Product Number

4

Dosage Form

-

Strength

EQ 12.5MG BASE;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-01-25

Regulatory Status

Discontinued

2013
25 Jan
Discontinued Application: 22426

Drug Name

OSENI

Product Number

6

Dosage Form

-

Strength

EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-01-25

22426 / 6

Active Ingredient

ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDE

Application Number

22426

Product Number

6

Dosage Form

-

Strength

EQ 12.5MG BASE;EQ 45MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-01-25

Regulatory Status

Discontinued

1995
10 May
Discontinued Application: 20406

Drug Name

PREVACID

Product Number

1

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1995-05-10

20406 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

20406

Product Number

1

Dosage Form

-

Strength

15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1995-05-10

Regulatory Status

Discontinued

2001
03 May
Discontinued Application: 21281

Drug Name

PREVACID

Product Number

1

Dosage Form

-

Strength

15MG/PACKET

Approval Date

2001-05-03

21281 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

21281

Product Number

1

Dosage Form

-

Strength

15MG/PACKET

Approval Date

2001-05-03

Regulatory Status

Discontinued

2001
03 May
Discontinued Application: 21281

Drug Name

PREVACID

Product Number

2

Dosage Form

-

Strength

30MG/PACKET

Approval Date

2001-05-03

21281 / 2

Active Ingredient

LANSOPRAZOLE

Application Number

21281

Product Number

2

Dosage Form

-

Strength

30MG/PACKET

Approval Date

2001-05-03

Regulatory Status

Discontinued

2004
27 May
Discontinued Application: 21566

Drug Name

PREVACID IV

Product Number

1

Dosage Form

-

Strength

30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2004-05-27

21566 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

21566

Product Number

1

Dosage Form

-

Strength

30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2004-05-27

Regulatory Status

Discontinued

2003
14 Nov
Discontinued Application: 21507

Drug Name

PREVACID NAPRAPAC 250 (COPACKAGED)

Product Number

2

Dosage Form

-

Strength

15MG,N/A;N/A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2003-11-14

21507 / 2

Active Ingredient

LANSOPRAZOLE; NAPROXEN

Application Number

21507

Product Number

2

Dosage Form

-

Strength

15MG,N/A;N/A,250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2003-11-14

Regulatory Status

Discontinued

2003
14 Nov
Discontinued Application: 21507

Drug Name

PREVACID NAPRAPAC 375 (COPACKAGED)

Product Number

3

Dosage Form

-

Strength

15MG,N/A;N/A,375MG

Approval Date

2003-11-14

21507 / 3

Active Ingredient

LANSOPRAZOLE; NAPROXEN

Application Number

21507

Product Number

3

Dosage Form

-

Strength

15MG,N/A;N/A,375MG

Approval Date

2003-11-14

Regulatory Status

Discontinued

2003
14 Nov
Discontinued Application: 21507

Drug Name

PREVACID NAPRAPAC 500 (COPACKAGED)

Product Number

4

Dosage Form

-

Strength

15MG,N/A;N/A,500MG

Approval Date

2003-11-14

21507 / 4

Active Ingredient

LANSOPRAZOLE; NAPROXEN

Application Number

21507

Product Number

4

Dosage Form

-

Strength

15MG,N/A;N/A,500MG

Approval Date

2003-11-14

Regulatory Status

Discontinued

1997
02 Dec
Discontinued Application: 50757

Drug Name

PREVPAC (COPACKAGED)

Product Number

1

Dosage Form

-

Strength

500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1997-12-02

50757 / 1

Active Ingredient

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE

Application Number

50757

Product Number

1

Dosage Form

-

Strength

500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1997-12-02

Regulatory Status

Discontinued

1996
06 Sep
Discontinued Application: 19815

Drug Name

PROAMATINE

Product Number

1

Dosage Form

-

Strength

2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-06

19815 / 1

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

19815

Product Number

1

Dosage Form

-

Strength

2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-06

Regulatory Status

Discontinued

1996
06 Sep
Discontinued Application: 19815

Drug Name

PROAMATINE

Product Number

2

Dosage Form

-

Strength

5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-06

19815 / 2

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

19815

Product Number

2

Dosage Form

-

Strength

5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

1996-09-06

Regulatory Status

Discontinued

2002
20 Mar
Discontinued Application: 19815

Drug Name

PROAMATINE

Product Number

3

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2002-03-20

19815 / 3

Active Ingredient

MIDODRINE HYDROCHLORIDE

Application Number

19815

Product Number

3

Dosage Form

-

Strength

10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2002-03-20

Regulatory Status

Discontinued

2013
30 Sep
Discontinued Application: 204447

Drug Name

TRINTELLIX

Product Number

3

Dosage Form

-

Strength

EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-09-30

204447 / 3

Active Ingredient

VORTIOXETINE HYDROBROMIDE

Application Number

204447

Product Number

3

Dosage Form

-

Strength

EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date

2013-09-30

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    8 View
  • EDQM CEP
    4 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    22 View
  • FDA Approved Drugs Database
    123 View
Drug Status Breakdown
31 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACTOPLUS MET

Application Number

21842

Product Number

1

Active Ingredient

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE

Dosage Form

-

Strength

500MG;EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.